v3.25.1
Condensed Consolidated Balance Sheets (Current Period Unaudited) - USD ($)
Mar. 31, 2025
Dec. 31, 2024
Current assets:    
Cash and cash equivalents $ 10,501,714 $ 8,999,496
Marketable securities 24,742,800 29,922,523
Prepaid expenses and other current assets 1,703,747 1,905,360
Grant receivable 1,629,227 2,254,231
Total current assets 38,577,488 43,081,610
Total assets 38,577,488 43,081,610
Current liabilities:    
Accounts payable 1,860,598 1,511,440
Accrued expenses and other current liabilities 2,082,403 2,367,842
Total liabilities 3,943,001 3,879,282
Commitments and Contingencies  
Stockholders’ Equity:    
Common stock, $0.001 par value: 1,000,000,000 shares authorized: 8,702,719 shares issued and outstanding at March 31, 2025 and December 31, 2024 8,702 8,702
Additional paid-in capital 110,230,080 109,868,913
Accumulated other comprehensive income 21,223 56,197
Accumulated deficit (75,625,518) (70,731,484)
Total stockholders' equity 34,634,487 39,202,328
Total liabilities and stockholders' equity 38,577,488 43,081,610
Series A Preferred Stock [Member]    
Stockholders’ Equity:    
Series A preferred stock $0.001 par value; 30,000,000 authorized at March 31, 2025 and December 31, 2024, 0 shares issued and outstanding at March 31, 2025 and December 31, 2024 $ 0 $ 0